Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma

Cancer

Volumn 88, Issue 7, 2000, Pages 1663-1670

  Cheng, Liang ^a   Neumann, Roxann M ^b   Nehra, Ajay ^b   Spotts, Bruce E ^b   Weaver, Amy L ^b   Bostwick, David G ^b,c  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

^c BOSTWICK LABORATORIES   (United States)

Author keywords

Bladder cancer; Grading; Heterogeneity; Progression; Ta classification; Transitional cell carcinoma; Urothelial carcinoma

Indexed keywords

BCG VACCINE; MITOMYCIN C; THIOTEPA;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER SURVIVAL; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; UROGENITAL TRACT CANCER; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; TIME FACTORS; URINARY BLADDER NEOPLASMS;

EID: 0034176243     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000401)88:7<1663::AID-CNCR21>3.0.CO;2-8     Document Type: Article

References (33)

1. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 2000;50:7-33.
2. Droller MJ. Bladder cancer: state-of-the-art care. CA Cancer J Clin 1998;48:269-84.
3. Mostofi FK, Sobin LH, Torloni H. Epithelial tumours. Histological typing of urinary bladder tumours. Volume 10. Geneva: World Health Organization, 1973;21-31.
4. Pauwels RPE, Schapers RFM, Smeets AWGB, Debruyne FMJ, Geraedts JPM. Grading in superficial bladder cancer: morphological criteria. Br J Urol 1988;61:129-34.
5. Bergkvist A, Ljungqvist A, Moberger G. Classification of bladder tumours based on the cellular pattern: a preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir Scand 1965; 130:371-8.
6. Malmstrom P, Busch C, Norlen BJ. Recurrence, progression and survival in bladder cancer: a retrospective analysis of 232 patients with ≥5-year followup. Scand J Urol Nephrol 1987;21:185-95.
7. Carbin B, Ekman P, Gustafson H, Christensen NJ, Sandstedt B, Silfversward C. Grading of human urothelial carcinoma based on nuclear atypia and mitotic frequency. I. Histological description. J Urol 1991;145:968-71.
8. Ash J. Epithelial tumors of the bladder. J Urol 1940;44:135-45.
9. Murphy WM, Beckwith JB, Farrow GM. Tumors of the kidney, bladder, and related urinary structures. In: Rosai J, editor. Atlas of tumor pathology. 3rd edition, Fascicle 11. Washington: Armed Forces of Institute of Pathology, 1994; 202-48.
10. Broders AC. Carcinoma grading and practical application. Arch Pathol Lab Med 1926;2:376-81.
11. Broders AC. The grading of carcinoma. Minn Med 1925;8: 726-30.
12. Epstein JI, Amin MB, Reuter VR, Mostofi FK, and the Bladder Consensus Conference Committee. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22:1435-8.
13. Fleming ID, Cooper JS, Henson DE, Hutter RVP, Kennedy BJ, Murphy GP, et al., editors. American Joint Committee on Cancer. Cancer staging manual. 5th edition. Philadelphia: Lippincott Raven, 1997.
14. Bostwick DG. Natural history of early bladder cancer. J Cell Biochem 1992;161(Suppl):31-8.
15. Eble JN, Young RH. Benign and low-grade papillary lesions of the urinary bladder: a review of the papilloma-papillary carcinoma controversy and a report of five typical papillomas. Semin Diagn Pathol 1989;6:351-71.
16. Amin M, Young R. Intraepithelial lesions of the urinary bladder with a discussion of the histogenesis of urothelial neoplasia. Semin Diagn Pathol 1997;14:84-97.
17. Chen SS, Chen KK, Lin ATL, Chang YH, Wu HHH, Hsu THS, et al. The significance of tumor grade in predicting disease progression in stage Ta transitional cell carcinoma of the urinary bladder. Br J Urol 1996;78:209-12.
18. Gibbons R, Mandler J, Harmann W. The significance of epithelial atypia seen in noninvasive transitional cell papillary tumors of the bladder. J Urol 1969;102:195-9.
19. England HR, Paris AMI, Blandy JP. The correlation of T1 bladder tumour history with prognosis and follow-up requirements. Br J Urol 1981;53:593-7.
20. Heney NM, Ahmed S, Flanagan MJ, Frable W, Corder MP, Hafermann MD, et al. Superficial bladder cancer: progression and recurrence. J Urol 1983;130:1083-6.
21. Heney NM. Natural history of superficial bladder cancer: prognostic features and long-term disease course. Urol Clin North Am 1992;19:429-33.
22. Torti FM, Lum BL, Aston D, MacKenzie N, Faysel M, Shortliffe LD, et al. Superficial bladder cancer: the primacy of grade in the development of invasive disease. J Clin Oncol 1987;5:125-30.
23. Takashi M, Sakata T, Murase T, Hamajima N, Miyake K. Grade 3 bladder cancer with lamina propria invasion (pT1): characteristics of tumor and clinical course. Nagoya J Med Sci 1991;53:1-8.
24. Cummings KB, Barone JG, Ward WS. Diagnosis and staging of bladder cancer. Urol Clin North Am 1992;19:455-65.
25. Fitzpatrick JM, West AB, Butler MR, Lane V, O'Flynn JD. Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection. J Urol 1986;135:920-2.
26. Herr HW. Natural history of superficial bladder tumors: 10-to 20-year follow-up of treated patients. World J Urol 1997; 15:84-8.
27. Hankey BF, Edwards BK, Ries LA, Percy CL, Shambaugh E. Problems in cancer surveillance: delineating in situ and invasive bladder cancer. J Natl Cancer Inst 1991;83: 384-5.
28. Holmang S, Hedelin H, Anderstrom C, Johnansson SL. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J Urol 1995;153:1823-7.
29. Jordan AM, Weingarten JW, Murphy WM. Transitional cell neoplasms of the urinary bladder: can biologic potential be predicted from histologic grade? Cancer 1987;60:2766-74.
30. Prout GR Jr., Barton B, Griffin P, Friedell G. Treated history of noninvasive grade 1 transitional cell carcinoma. J Urol 1992;148:1413-9.
31. Cheng L, Neumann RM, Bostwick DG. Papillary urothelial neoplasms of low malignant potential: clinical and biologic implications. Cancer 1999;86:2102-8.
32. Gilbert HA, Logan JL, Kagan AR, Friedman HA, Cove JK, Fox M, et al. The natural history of papillary transitional cell carcinoma of the bladder and its treatment in any unselected population on the basis of histologic grading. J Urol 1978;119:488-92.
33. Pocock RD, Ponder BAJ, O'Sullivan JP, Ibrahim SK, Easton DF, Shearer RJ. Prognostic factors in non-infiltrating carcinoma of the bladder: a preliminary report. Br J Urol 1982; 54:711-5.